- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PD-1 Inhibitor
Total 6158 results
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | G-CSFChina
-
Baodong QinUnknownChemotherapy Effect | Immunotherapy | Tumor Mutation Burden | PD-1/L1 InhibitorChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | Granulocyte Colony-Stimulating FactorChina
-
Peking UniversityUnknownPatients With Digestive System Tumors Resistant to PD-1 Inhibitors
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingStereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLCChina
-
Peking Union Medical College HospitalRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | RegorafenibChina
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | Lenvatinib | Hepatic Arterial Infusion ChemotherapyChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RecruitingCarcinoma | Digestive System Neoplasms | Intrahepatic Cholangiocarcinoma | First-line Treatment | PD-1 InhibitorChina
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Stereotactic Body Radiotherapy | Low Dose RadiotherapyChina
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Peking UniversityNot yet recruitingGastroesophageal Junction Cancer | Chemoradiotherapy | PD-1
-
Peking University Third HospitalCompletedPancreatic Cancer | Stereotactic Body Radiotherapy | PD-1 InhibitorsChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Pd-1 InhibitorsChina
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
Xiaorong DongUnknown
-
Fujian Cancer HospitalNot yet recruitingLung Adenocarcinoma | PD-1 Inhibitor | Stage IV Non-small Cell Lung Cancer | VEGF
-
Beijing Friendship HospitalNot yet recruiting
-
Nanfang Hospital of Southern Medical UniversityRecruitingEsophageal Squamous Cell Carcinoma | PD-1 InhibitorChina
-
Fudan UniversityNot yet recruitingthe Efficacy and Safety of PD-1 Inhibitors With or Without Radiotherapy in Patients With Advanced MelanomaChina
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingNasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 InhibitorChina
-
Fuzhou General HospitalUnknownSmall Cell Lung Cancer | Lung Neoplasm | PD-1 InhibitorsChina
-
Tang-Du HospitalRecruitingChemotherapy | Esophageal Squamous Cell Carcinoma | PD-1 Inhibitor | NeoadjuventChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaboratorsNot yet recruitingNasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
-
Sichuan Cancer Hospital and Research InstituteActive, not recruitingNasopharyngeal Carcinoma | Chemoradiotherapy | PD-1 InhibitorsChina
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruiting
-
Indiana Hemophilia &Thrombosis Center, Inc.Active, not recruitingPlasminogen Activator Inhibitor-1 Deficiency | Cardiac FibrosisUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingCancer | Thyroid | PD-1United States
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; Sun Yat-sen University; Ningbo Medical Center Lihuili... and other collaboratorsRecruitingPlaque, Atherosclerotic | Programmed Cell Death Protein 1 InhibitorChina
-
Xijing HospitalRecruitingPD-1 | Locally Advanced Gastric AdenocarcinomaChina
-
Wuhan Union Hospital, ChinaRecruitingGastroesophageal Junction Cancer | PD-1 | Neoadjuvant ChemoradiotherapyChina
-
Novartis PharmaceuticalsRecruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationItaly, Spain, United States, France, Thailand, Malaysia, China, Germany, India, Turkey, Belgium, Argentina, Bulgaria, Netherlands, Hungary, Greece, Portugal, Austria, Singapore, Brazil, United Kingdom
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Plaque, Atherosclerotic | Immune Checkpoint Inhibitors | Programmed Cell Death Protein 1 Inhibitor | Intimal Medial Thickness of Internal Carotid ArteryChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingIntrahepatic Cholangiocarcinoma | Apatinib | PD-1 Antibody | Transarterial ChemoembolizationChina
-
Ascletis Pharmaceuticals Co., Ltd.RecruitingHIV Infections | HIV-1-infection | PD-L1 Gene MutationChina
-
Beijing Friendship HospitalNot yet recruiting
-
Samsung Medical CenterUnknown
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
China Medical University, ChinaNot yet recruitingPD-1 Antibody | Gastrointestinal Tumours | DC-Cell | NK-Cell
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
The Second Affiliated Hospital of Harbin Medical...UnknownContract Management PD